Acesion Pharma Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met
Search for Articles
Mar 14, 2023
Feb 27, 2023
Puzzle Medical Closes CAN$ 34 million Series A Funding Round to Complete Human Feasibility Study Led by Cordis-X
Feb 16, 2023
HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards
Feb 9, 2023
Basking Biosciences Presents Positive Clinical Results from Safety and Dose-Escalation Study for First Reversible Thrombolytic Agent at ISC 2023
Jan 31, 2023